ES2061745T3 - Aislamiento, purificacion, caracterizacion, clonacion y secuenciacion de n-alfa-acetiltransferasa. - Google Patents

Aislamiento, purificacion, caracterizacion, clonacion y secuenciacion de n-alfa-acetiltransferasa.

Info

Publication number
ES2061745T3
ES2061745T3 ES89102006T ES89102006T ES2061745T3 ES 2061745 T3 ES2061745 T3 ES 2061745T3 ES 89102006 T ES89102006 T ES 89102006T ES 89102006 T ES89102006 T ES 89102006T ES 2061745 T3 ES2061745 T3 ES 2061745T3
Authority
ES
Spain
Prior art keywords
alpha
cloning
sequencing
characterization
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102006T
Other languages
English (en)
Inventor
John A Smith
Fang-Jen S Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of ES2061745T3 publication Critical patent/ES2061745T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

SE AISLAN Y PURIFICAN UNAS N ALFA - ACETILTRANSFERENCIA CON UN PESO MOLECULAR DE ALREDEDOR DE 180000 UNIDADES DALTON COMPUESTAS DE DOS SUBUNIDADES DE GRUPOS PEPTONA TENIENDO PESOS MOLECULARES DE ALREDEDOR DE 95000 CADA UNO, TENIENDO ALTA ACTIVIDAD ENCIMATICA. LA CODIFICACION DE GENE PARA ESTE ENCIMA SE AISLA Y SECUENCIA. EL PUEDE SER INCORPORADO DENTRO DE MOLECULAS DE DNA RECOMBINANDO Y REPRESENTANDO UN VEHICULO PARA TRANSFORMACION DE CELULAS, ESPECIALMENTE CELULAS DE PLANTAS. ESTAS CELULAS PUEDEN CULTIVARSE PARA PLANTAS TENIENDO CAPACIDAD DE MEJORAR LA ACETILACCION.
ES89102006T 1988-02-08 1989-02-06 Aislamiento, purificacion, caracterizacion, clonacion y secuenciacion de n-alfa-acetiltransferasa. Expired - Lifetime ES2061745T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15336188A 1988-02-08 1988-02-08
US07/284,344 US4966848A (en) 1988-02-08 1988-12-14 Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase

Publications (1)

Publication Number Publication Date
ES2061745T3 true ES2061745T3 (es) 1994-12-16

Family

ID=26850470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102006T Expired - Lifetime ES2061745T3 (es) 1988-02-08 1989-02-06 Aislamiento, purificacion, caracterizacion, clonacion y secuenciacion de n-alfa-acetiltransferasa.

Country Status (9)

Country Link
US (1) US4966848A (es)
EP (1) EP0334004B1 (es)
JP (1) JPH03502403A (es)
DE (1) DE68910713T2 (es)
DK (1) DK186390D0 (es)
ES (1) ES2061745T3 (es)
IE (1) IE890386L (es)
PT (1) PT89611B (es)
WO (1) WO1989007138A1 (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128459A (en) * 1988-02-08 1992-07-07 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N alpha-acetyltransferase
US5656458A (en) * 1988-11-04 1997-08-12 Chiron Corporation Expression and processing of amino terminus acetylated FGF's in yeast
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
AU640428B2 (en) * 1989-10-25 1993-08-26 General Hospital Corporation, The Isolating of strains of saccharomyces cerevisiae having altered nalpha-acetyltransferase activity
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
NO986133D0 (no) 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
FR2807523B1 (fr) * 2000-04-07 2002-08-30 Inst Nat Sante Rech Med UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
EP1432728A4 (en) * 2001-08-30 2007-10-24 Praecis Pharm Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
CA2517149A1 (en) * 2003-03-07 2004-09-16 University College Cork - National University Of Ireland, Cork A process for the synthesis of a chromatographic phase
WO2005051982A1 (ja) * 2003-11-28 2005-06-09 Toagosei Co,. Ltd. 糖ペプチド及び温度応答性ミセル
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
EP1785431B1 (en) * 2004-08-30 2016-01-20 Toray Industries, Inc. Fractionation apparatus
US8044028B2 (en) * 2004-10-18 2011-10-25 Cognis France S.A.S. Oligopeptides and their use in cosmetics
US7563764B2 (en) * 2004-12-30 2009-07-21 E. I. Du Pont De Nemours And Company Antimicrobial peptides based on tripeptide repeats
NZ577196A (en) 2005-01-20 2011-06-30 Biomarck Pharmaceuticals Ltd Mucin hypersecretion inhibitors based on the structure of MANS and methods of use
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
TWI303567B (en) * 2005-12-20 2008-12-01 Ind Tech Res Inst Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
WO2007098033A2 (en) 2006-02-16 2007-08-30 University Of Georgia Research Foundation, Inc . Feedback prodrug
CA2641908A1 (en) * 2006-02-23 2007-08-30 Fibrex Medical Research & Development Gmbh Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
CN103990111B (zh) * 2006-07-26 2016-08-31 拜欧马克医药有限公司 减少炎症介质释放的方法和可用于该方法的肽
US8507434B2 (en) * 2007-01-03 2013-08-13 The Johns Hopkins University Peptide modulators of angiogenesis and use thereof
DK2120991T3 (da) * 2007-02-12 2014-04-28 Biotempt Bv Behandling af traumatisk blødning med korte oligopeptider
JP2011528566A (ja) * 2008-07-21 2011-11-24 コンプジェン リミティッド アンジオポエチン由来ペプチド
FR2940969B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
US8518957B2 (en) * 2009-12-02 2013-08-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure
EP2382963A1 (en) * 2010-04-29 2011-11-02 Cognis IP Management GmbH Cosmetic composition containing oligopeptides
AU2012208283B2 (en) 2011-01-20 2017-01-05 Oneday - Biotech And Pharma Ltd. Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
WO2012123018A1 (en) * 2011-03-15 2012-09-20 Nanomed3D S.R.L. Functionalized biomaterials for tissue regeneration
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
US9452225B2 (en) * 2012-03-01 2016-09-27 Novo Nordisk A/S GLP-1 prodrugs
CA2879019A1 (en) 2012-07-23 2014-01-30 Oneday - Biotech And Pharma Ltd. Glutathione-elevating compositions and uses thereof
WO2014016837A1 (en) 2012-07-25 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions and methods for increasing carnitine level in muscle tissues
DK2891663T3 (en) * 2012-08-31 2018-03-26 Vasculead Inc PSF1-Derived Peptide
JP6285447B2 (ja) * 2012-10-17 2018-02-28 ノヴォ ノルディスク アー／エス 経口ペプチド送達用の脂肪酸アシル化ｄ−アミノ酸
WO2015173802A1 (en) * 2014-05-11 2015-11-19 Tel Hashomer Medical Research Infrastructure And Services Ltd. Par-1 based therapeutic conjugates and uses thereof
KR101470793B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 흡수촉진제로서의 펩타이드와 이를 포함하는 조성물
WO2016129174A1 (ja) * 2015-02-09 2016-08-18 株式会社ファーマフーズ ヒアルロン酸産生促進剤
US9856302B2 (en) * 2015-07-23 2018-01-02 General Biologicals Corporation Anti-microbial peptide and method for treating microbial infection
EP3350200A4 (en) * 2015-09-18 2019-03-27 Wake Forest University Health Services ANGIOTENSIN (1 7) ANALOGUE AND ASSOCIATED PROCEDURES
TWI675851B (zh) * 2015-12-14 2019-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
US10286038B2 (en) * 2016-03-11 2019-05-14 Northwestern University Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
EP3454879B1 (en) * 2016-05-10 2021-12-22 INSERM (Institut National de la Santé et de la Recherche Médicale) New compounds and pharmaceutical use thereof in the treatment of cancer
WO2017218355A1 (en) * 2016-06-15 2017-12-21 Counterpoint Biomedica Llc Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
WO2018045155A1 (en) * 2016-09-02 2018-03-08 The Board Of Trustees Of The University Of Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
CA3046927A1 (en) * 2016-12-13 2018-06-21 Emory University Polypeptides for managing viral infections
US11116817B2 (en) * 2017-02-17 2021-09-14 The Curators Of The University Of Missouri Antimicrobial agents and compositions comprising the same
US10570177B2 (en) * 2017-03-01 2020-02-25 The Chinese University Of Hong Kong P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
RU2678987C2 (ru) * 2017-04-28 2019-02-05 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Пептид для лечения болезни альцгеймера
EP3628047A1 (en) * 2017-05-02 2020-04-01 Sanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
WO2019211829A1 (en) 2018-05-02 2019-11-07 Tel Hashomer Medical Research Infrastructure And Services Ltd. Compositions and methods for treating glioblastoma
KR102234027B1 (ko) * 2018-05-09 2021-03-31 서울대학교산학협력단 B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도
AU2020207203A1 (en) * 2019-01-07 2021-08-19 Cenna Biosciences Inc. Novel peptides and uses thereof
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (en) 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
JP2022537318A (ja) 2019-06-17 2022-08-25 バイオマルク ファーマシューティカルズ リミテッド ぶどう膜炎の処置におけるペプチド及びその使用の方法
US20210009639A1 (en) 2019-07-12 2021-01-14 Northwestern University Insulin like growth factor binding protein bioactive peptide fragments
US20240309060A1 (en) * 2023-03-17 2024-09-19 Trustees Of Boston University Polypeptide bax/npm inhibitors

Also Published As

Publication number Publication date
JPH03502403A (ja) 1991-06-06
AU616492B2 (en) 1991-10-31
AU3196989A (en) 1989-08-25
DK186390A (da) 1990-08-03
EP0334004A1 (en) 1989-09-27
DK186390D0 (da) 1990-08-03
EP0334004B1 (en) 1993-11-18
WO1989007138A1 (en) 1989-08-10
US4966848A (en) 1990-10-30
DE68910713D1 (de) 1993-12-23
IE890386L (en) 1989-08-08
PT89611B (pt) 1994-05-31
DE68910713T2 (de) 1994-04-07
PT89611A (pt) 1989-10-04

Similar Documents

Publication Publication Date Title
ES2061745T3 (es) Aislamiento, purificacion, caracterizacion, clonacion y secuenciacion de n-alfa-acetiltransferasa.
Nechushtai et al. Photosystem I reaction center from the thermophilic cyanobacterium Mastigocladus laminosus
ATE85361T1 (de) Molekulare zuechtung.
DE3750755D1 (de) Anti-sense-Regulierung von Genexpression in Pflanzenzellen.
NO870328L (no) Fremg. for ekspresjon av gener i planter, plantedeler og plantecellekulturer, og dna-fragmenter, plasmider og transformerte mikroorganismer for anvendelse ved fremg, samt anvendelse av disse for ekspresjon av gener i planter
CA2208751A1 (en) Oil body proteins as carriers of high value proteins
DE3878699D1 (de) In pflanzen wirksames resistenzgen gegen phosphinothricin und seine verwendung.
BR9915704A (pt) ácido nucleico isolado, preparação purificada de um polipeptìdeo, célula recombinante, vetor, anticorpo especìfico, sequência de ácido nucleico isolado, planta, célula de planta, órgão de planta, flor de planta, tecido de planta, semente de planta ou progênie de planta e processos para manipulação do ácido nucleico em uma planta e da expressão de erfi em uma célula de planta, para identificação de um composto capaz de afetar a resposta ao etileno no sistema de sinalização de etileno em uma planta e para geração de uma planta
ATE92530T1 (de) Transformation und expression eines fremden gens in -i(brassica) spezies.
UA43314C2 (uk) Фрагмент виділеної днк, що кодує дельта-6-десатуразу ціанобактерій (варіанти), вектор, спосіб одержання рослини з підвищеним вмістом гамма-ліноленової кислоти (варіанти), спосіб індукування продукції гамма-ліноленової кислоти (варіанти), спосіб індукування продукції октадекатетраєнової кислоти (варіанти) та ціанобактеріальна дельта-6-десатураза
SE7907573L (sv) Sett att odla och/eller festa celler i ett odlingsmedium innehallande partikelformiga mikroberare
NO171983C (no) Fremstilling av polypeptider med human-gammainterferon-aktivitet og dna-sekvens derav
DE69939944D1 (de) Vektoren zum transformieren von pflanzen
ATE256741T1 (de) Pflanzen mit modifizierter reaktion auf ethylen
DE69804463D1 (de) Kationische polymere, diese kationische polymere enthaltende komplexe und wenigstens eine negative ladung enthaltende therapeutisch wirksame mittel, insbesondere nukleinsäuren und ihre verwendung in gentherapie
Schwartz Genetic studies on mutant enzymes in maize, V. in vitro interconversion of allelic isozymes
Aoyama et al. A common mechanism of transcriptional activation by the three positive regulators, VirG, PhoB, and OmpR
BR9811853A (pt) Processos para aumentar o rendimento em plantas
Bonen et al. Ribosomal RNA homologies and the evolution of the filamentous blue-green bacteria
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
DE3689383D1 (de) Pflanzenkulturzelle und ihre Verwendung.
EP0322084A3 (en) Tumor cell inhibition factor
KR920003989A (ko) 콘드로모듈린-i 단백질
Nolan Cleaning up with biotechnology
Martzen ISOLATION OF PEPSIN ISOINHIBITORS FROM ASCARIS SUUM AND ASCARIS HOMINIS BY AFFINITY CHROMATOGRAPHY AND CHARACTERIZATION OF THE ISOINHIBITORS.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334004

Country of ref document: ES